Skip to content
lifestyle.paraskevas.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Mereo BioPharma Group plc
Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights
August 11, 2026
Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
August 11, 2026
Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates
May 12, 2026
Mereo BioPharma Reports Full Year 2025 Financial Results and Provides Corporate Highlights
March 19, 2026